Literature DB >> 33047191

Mechanisms of RANKL delivery to the osteoclast precursor cell surface.

Masashi Honma1, Yuki Ikebuchi2, Hiroshi Suzuki2.   

Abstract

RANKL is biosynthesized as a single-pass transmembrane protein, and soluble molecular species are produced by enzymatic cleavage at the cell surface. Recent studies have revealed that the transmembrane form of RANKL is a major contributor to the induction of mature osteoclasts under physiological conditions in vivo. In osteoblasts and osteocytes, most newly synthesized RANKL forms a protein complex with OPG and is selectively sorted to lysosomes. Only the small proportion of newly synthesized RANKL that does not form a complex with OPG is transported to the cell surface. Then, the transmembrane RANKL is delivered to the surface of osteoclast precursors to stimulate RANK, and induces the activation of a downstream signaling pathway. The ability of osteocytes to support the formation of mature osteoclasts appears to depend upon the amount of RANKL molecules present on their cell surfaces. However, the way in which osteocytes, which are embedded in the bone matrix, deliver transmembrane RANKL to the cell surfaces of osteoclast precursors, which are localized in the bone marrow cavity, remains to be elucidated. Further studies are needed to clarify the mechanisms underlying this process.

Entities:  

Keywords:  OPG; Osteoclast; Osteocyte; RANKL; RANKL reverse signaling

Year:  2020        PMID: 33047191     DOI: 10.1007/s00774-020-01157-3

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  34 in total

1.  A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling.

Authors:  F K Chan; H J Chun; L Zheng; R M Siegel; K L Bui; M J Lenardo
Journal:  Science       Date:  2000-06-30       Impact factor: 47.728

2.  Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-kappaB ligand.

Authors:  Atsuhiko Hikita; Ikuo Yana; Hidetoshi Wakeyama; Masaki Nakamura; Yuho Kadono; Yasushi Oshima; Kozo Nakamura; Motoharu Seiki; Sakae Tanaka
Journal:  J Biol Chem       Date:  2006-10-03       Impact factor: 5.157

3.  Osteoblastic cells are involved in osteoclast formation.

Authors:  N Takahashi; T Akatsu; N Udagawa; T Sasaki; A Yamaguchi; J M Moseley; T J Martin; T Suda
Journal:  Endocrinology       Date:  1988-11       Impact factor: 4.736

4.  Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity.

Authors:  J Lam; C A Nelson; F P Ross; S L Teitelbaum; D H Fremont
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

5.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

Authors:  H Yasuda; N Shima; N Nakagawa; K Yamaguchi; M Kinosaki; S Mochizuki; A Tomoyasu; K Yano; M Goto; A Murakami; E Tsuda; T Morinaga; K Higashio; N Udagawa; N Takahashi; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

6.  Soluble RANKL is physiologically dispensable but accelerates tumour metastasis to bone.

Authors:  Tatsuo Asano; Kazuo Okamoto; Yuta Nakai; Masanori Tsutsumi; Ryunosuke Muro; Ayako Suematsu; Kyoko Hashimoto; Tadashi Okamura; Shogo Ehata; Takeshi Nitta; Hiroshi Takayanagi
Journal:  Nat Metab       Date:  2019-09-02

7.  Evaluation of pharmaceuticals with a novel 50-hour animal model of bone loss.

Authors:  Yoshiya Tomimori; Kaoru Mori; Masanori Koide; Yuko Nakamichi; Tadashi Ninomiya; Nobuyuki Udagawa; Hisataka Yasuda
Journal:  J Bone Miner Res       Date:  2009-07       Impact factor: 6.741

Review 8.  Principles of antibody-mediated TNF receptor activation.

Authors:  H Wajant
Journal:  Cell Death Differ       Date:  2015-08-21       Impact factor: 15.828

9.  MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover.

Authors:  K Holmbeck; P Bianco; J Caterina; S Yamada; M Kromer; S A Kuznetsov; M Mankani; P G Robey; A R Poole; I Pidoux; J M Ward; H Birkedal-Hansen
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

10.  Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss.

Authors:  Jinhu Xiong; Keisha Cawley; Marilina Piemontese; Yuko Fujiwara; Haibo Zhao; Joseph J Goellner; Charles A O'Brien
Journal:  Nat Commun       Date:  2018-07-25       Impact factor: 14.919

View more
  2 in total

Review 1.  Bone remodeling: an operational process ensuring survival and bone mechanical competence.

Authors:  Simona Bolamperti; Isabella Villa; Alessandro Rubinacci
Journal:  Bone Res       Date:  2022-07-18       Impact factor: 13.362

2.  Traditional Chinese decoction Si Zhi Wan attenuates ovariectomy (OVX)-induced bone loss by inhibiting osteoclastogenesis and promoting apoptosis of mature osteoclasts.

Authors:  Qingman He; Kanghua Fu; Huan Yao; Shujun Wei; Li Xiang; Sixian Liu; Tao Chen; Yongxiang Gao
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.